Last $9.11 USD
Change Today -0.04 / -0.44%
Volume 282.0K
ACHI On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 8:10 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

accretive health inc (ACHI) Snapshot

Open
$9.11
Previous Close
$9.15
Day High
$9.16
Day Low
$9.05
52 Week High
07/24/13 - $10.77
52 Week Low
05/15/14 - $6.92
Market Cap
886.1M
Average Volume 10 Days
773.6K
EPS TTM
$0.19
Shares Outstanding
97.3M
EX-Date
--
P/E TM
48.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for ACCRETIVE HEALTH INC (ACHI)

accretive health inc (ACHI) Related Businessweek News

No Related Businessweek News Found

accretive health inc (ACHI) Details

Accretive Health, Inc. provides revenue cycle management services for hospitals and healthcare providers in the United States. It offers integrated revenue cycle management services that help healthcare providers to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections; quality and total cost of care services, which enable healthcare providers to manage the health of a defined patient population by identifying those individuals who are most likely to experience an adverse health event; and physician advisory services. Accretive Health, Inc. serves multi-hospital systems, including faith-based or community healthcare systems, academic medical centers, independent ambulatory clinics, and physician practice groups. The company was formerly known as Healthcare Services, Inc. and changed its name to Accretive Health, Inc. in August 2009. Accretive Health, Inc. was founded in 2003 and is headquartered in Chicago, Illinois.

2,700 Employees
Last Reported Date: 11/8/12
Founded in 2003

accretive health inc (ACHI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

accretive health inc (ACHI) Key Developments

Accretive Health, Inc. - Special Call

To discuss the appointment of Emad Rizk, M.D. as President and CEO

Accretive Health, Inc. Appoints Emad Rizk, M.D. as Chief Executive Officer, President, and a Member of the Board of Directors, Effective July 21, 2014

Accretive Health, Inc. announced that its board of directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions, as Chief Executive Officer, President, and a member of the board of directors, effective July 21, 2014. Prior to joining McKesson, Dr. Rizk served as senior partner and global director of Deloitte Consulting, prior to which he was worldwide medical director for Monsanto Corporation. He also currently serves on the board of Accuray Incorporated.

Accretive Health, Inc. Appoints Thomas J. Gibson as its Senior Vice President, Corporate Controller and Chief Accounting Officer

Accretive Health, Inc. appointed Thomas J. Gibson as its Senior Vice President, Corporate Controller and Chief Accounting Officer (the Company’s principal accounting officer). From August 2013 until December 2013, Mr. Gibson served as Chief Accounting Officer of Greenway Medical Technologies, Inc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACHI:US $9.11 USD -0.04

ACHI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huron Consulting Group Inc $65.54 USD +0.04
MedAssets Inc $24.48 USD +0.07
Navigant Consulting Inc $16.95 USD +0.14
Advisory Board Co/The $50.13 USD -0.12
WebMD Health Corp $50.04 USD 0.00
View Industry Companies
 

Industry Analysis

ACHI

Industry Average

Valuation ACHI Industry Range
Price/Earnings 55.3x
Price/Sales 0.9x
Price/Book 3.5x
Price/Cash Flow 52.8x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACCRETIVE HEALTH INC, please visit www.accretivehealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.